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We have recently demonstrated a synchronous eleva-
tion in the expression of mRNA for type I, type III 
procollagen and transforming growth factor-Pl in 
post-burn hypertrophic scar tissue compared to nor-
mal skin obtained from the same patient. In an attempt 
to examine whether these effects are phenotypically 
persistent, we compared the expression of mRNA for 
transforming growth factor-Pl in cultured fibroblasts 
from post-burn hypertrophic scar and normal dermis 
established from the same patients at passages 3, 5, 7, 
and 10. When a cDNA probe specific for transforming 
growth factor-pt was used, a transcript with an appar-
ent size of 2.5 kb was detected in both hypertrophic 
and normal fibroblasts at various passages. This cDNA 
Extensive thermal injury often leads to an abnormality in collagen metabolism that is a characteristic feature of fibrosis, including hypertrophic scarring and the related but more exuberant condition known as keloid [1]. It has been demonstrated that fibroblasts from keloid and hy-
pertrophic scar (HSc) tissues overexpress collagen mRNA and pro-
tein [2,3]. Our previous studies [4] revealed some variability in the 
expression of pro alpha 1(1) mRNA in six fibroblast strains estab-
lished from post-burn hypertrophic scar tissue. Quantitative analy-
sis of northern blots revealed a 28.5% increase in the overall expres-
sion of this transcript in hypertrophic scar fibroblasts compared to 
normal dermal fibroblasts from the same patient. In contrast, the 
expression of type I procollagen mRNA was at least twofold higher 
in post-burn HSc tissue compared to normal dermal tissue from the 
same patient [5]. This discrepancy between the in vitro and i,., vivo 
expression of procollagen mRNA could be explained iflocally syn-
thesized growth factors up-regulate collagen production at the site 
of injury. 
Several recent studies [6 - 8] have shown that transforming 
growth factor-PI (TGF-PI) promotes the synthesis of extracellular 
matrix proteins, including coll agen. Our previous work showed 
coincidental elevation in the expression of mRNA for type I, type 
III procollagen and TGF-PI in post-burn HSc tissue [5]. To examine 
whether the elevated expression of TGF-PI is phenotypically per-
sistent, we have established cultures from three post-burn HSc tis-
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also hybridized with a transcript with an apparent size 
of 4.9 kb. The abundance of the 2.5-kb transcript was 
decreased to 64% and 33% in hypertrophic scar and 
normal fibroblasts respectively, between passage 3 and 
7, whereas the intensity of the 4.9-kb message was not 
significantly altered. This change seems to be selective 
because no significant alteration in the expression of 
mRNA for the heat-shock-like protein (Nb29) was 
observed. These findings suggest that the effect of pas-
sage on the expression of transforming growth factor-
Pl in hypertrophic scar tissue fibroblasts is more pro-
nounced than in normal cells derived from the same 
patient. Key words: burn/collagen. ] Invest Dermatol 
103:684-686, 1994 
sues and measured the level of this mRNA through several passages 
(passages 3, 5, 7, and 10). Normal fibroblast cultures established 
from the same patients were used as controls. 
MATERIALS AND METHODS 
Clinical Specimens Patients who suffered thermal injury and were 
treated at the University of Alberta Hospital, Firefighters' Burn Treatment 
Unit were subjects for this study. Scars from three patients (Table I) who 
developed clinical evidence of hyperemic, raised, thickened, pruritic, and 
noncompliant scars confined to the site of injury were biopsied using a 6-mm 
punch following informed consent. A biopsy from normal uninjured skin 
was also obtained. 
Cell Culture Cultures of fibroblasts from normal skin and HSc tissue 
were established as previously described [4). Serial cell cultures at passages 3, 
5,7, and 10 were used for the analysis of mRNA for TGF-p,. 
RNA Extraction and Hybridization Forty eight hours prior to RNA 
extraction, the cell-cultu.re medium in each flask was replaced with the same 
medium containing 50 flg/ml ascorbic acid, 50 flg/ml beta-aminopropioni-
trile , 0.1 mM proline, and 10% dialyzed fetal bovine serum [9]. Following 
incubation, culture medium was removed and cel l layers were lysed in 6 ml 
of guanidinium thiocyanate (GITC) as previously described [4,9)' Extraction 
of total RNA from each individual cell lysate was performed using the 
GITC/CsCI procedure of Chirgwin et a/ [10]' Total RNA was then sepa-
rated by electrophoresis and blotted onto nitrocellulose filters [11). Fi lters 
were then baked under vacuum for 2 h at 80" C and pre-hybridized in a 
pre-hybridization solution for 4-6 hat 42"C, as described [4) . Hybridiza-
tion with eDNA probes for human TGF-p, and for the constitutively ex-
pressed heat shock- like protein Nb29 (12), and subsequent washing, were as 
described [4,5]. Autoradiography was performed by exposing Kodak X-
Omat film to the nitrocel lulose filters at -70"C in the presence of an 
enhancing screen. 
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Table I. Source of Hum.an Post-Burn Hypertrophic Scar 
and Normal Dermal Fibroblasts· 
Cell Biopsy Age TBSA Months 
Patient Strain Site (Years) Sex (%) Post-Burn 
HSc Chest 32 M 60 5 
N 
2 HSc Leg 50 M 28 4 
N 
3 HSc Hand 18 M 80 8 
N 
• Cultured fibroblasts were established from each HSc and normal sk.in obtained from 
the same patient as described under Materials a"d Met/rods. The patient's age, sex, and size 
of origina l body surface area injured (TBSA) is indicated as well as the site of biopsy and 
the number of months followin g initial injury. N, normal dermal fibroblasts. 
RESULTS 
Expression of mRNA for TGF-p A cDNA probe specific for 
human TGF-Pl visualized transcripts of apparent size 2.5 kb and 
4.9 kb in samples from three different human hypertrophic and 
normal fibroblast cell strains (Fig 1A,B,C). As shown in this figure, 
the 2.5-kb transcript was significantly less abundant in HSc fibro-
blasts as the passage number increased. This reduction was less pro-
nounced in normal cells from the same patient. When the blot 
corresponding to the autoradiogram shown in Fig 1C was re-hybri-
dized with Nb29 cON A for heat shock -like protein, no significant 
reduction in mRNA expression of this transcript with serial passage 
was observed (Fig 1D). This demonstrates that the reduction seen 
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Figure 1. Serial passages reduce the expression of TGF-P. in post-
burn hypertrophic and normal dermal fibroblasts. Total RNA from 
three independent hypertrophic (H) and normal (N) fibroblast cultures were 
separately pooled for each passage (passages 3, 5, 7, and 10) and electrophor-
esed on a 1 % agarose gel (10 J.Lg/lane). Nitrocellulose filters were then 
hybridized with a cDNA specific for TGF-P. (2.5- and 4.9-kb transcripts). 
A, B, and C show the pattern ofTGF-P. expression in three pool samples 
prepared from hypertrophic and normal fibroblasts at different passages; D 
demonstrates re-hybridization of the blot seen in C with a cDN A specific for 
Nb29 mRN A (Nb29 transcript) to demonstrate the RNA loading and speci-
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Figure 2 . Quantitative analysis of TGF-Pt mRNA expression in 
post-burn HSc and normal fibroblast cultures at different passages. 
Autoradiograms of three pooled samples were quantitated by densitometry 
and the relative expression of TGF-P. mRNA in hypertrophic (top) and 
normal (bottolll) fibroblasts at passages 5, 7, and 10 was compared to that of 
passage 3. Opetl and solid bars represent the mean ± SEM values for 2.5- and 
4.9-kb transcripts, respectively. • represents p < 0.05 for the difference in 
the mean ± SEM values of TGF-P./Nb29 mRNA for autoradiograms 
shown in Fig lA,B,C between cells at passage 3 and those at passage 7 and 10 
using the Student t test. 
in the 2.5 kb TGF-Pl transcript after serial passages is not related to 
variations in total R N A loading. The relative expression of these 
transcripts at passages 5, 7, and 10 in three different blots (Fig 1) 
was individually quantitated by densitometry and compared to that 
at passage 3 (Fig 2). The results show that the expression of the 
2.5-kb transcript in post-burn HSc fibroblast cultures decreased sig-
nificantly (37 ± 9 versus 100 ± 12, P < 0.05) at passage 7 relative 
to that of passage 3 (Fig 2, top, open bars), whereas the reduction 
seen in normal cells was less pronounced (67 ± 15 versus 100 ± 18) 
at this passage (Fig 2, bottom, open bars). T he overall abundance of 
the 4.9-kb transcript was also not significantly altered in HSc (Fig 
2, top, solid bars) or normal fibroblasts (Fig 2, bottom, solid bars) as 
the passage number increased. 
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DISCUSSION 
Although it was earlier shown that platelets, activated T lympho-
cytes, and macrophages were the major sources ofTGF-p [13 -15] , 
later studies revealed the presence of this growth factor in a number 
of other cell types and organs [16]. Our data on the expression of 
TGF-Pt mRNA in both post-burn HSc and normal tissues and in 
cultured fibroblasts established from these tissues suggest that these 
cells also may be capable of expressing TGF-Pt at the site of injury 
[5]. The expression of mRNA for this growth factor by fibroblasts 
of diffuse fasciitis has been reported [7]. Both HSc and normal 
fibroblasts in culture express the 2.5-kb transcript for TGF-Pt that 
has been reported in a number of cell lines and tissues, including 
T-47D human breast cancer cells [17] and megakaryoblasts [18]. 
These cells also express an unidentified transcript (4.9 kb) that has 
recently been reported in normal human simian cells [19] and in 
human breast cancer cells [17]. This transcript is unlikely to be due 
to a non-specific hybridization of TGF-Pt cDNA with 28S ribo-
somal RNA because it was still detectable when polyadenylated 
mRNA was used [17]. The reason for the expression of two differ-
ent transcripts for TGF-Pt by dermal fibroblasts is not clear but may 
be related to alternate patterns of mRNA splicing [19]. 
Our data show that the effect of passage on expression ofTGF-Pt 
is more pronounced in HSc fibroblasts than in normal fibroblasts 
obtained from the same patients. Furthermore, passaging the cells 
had a differential effect on the expression of the 2.5-kb transcript of 
TGF-Pt and the unidentified 4.9-kb message in post-burn HSc fi-
broblasts. As there is no comparable study in the literature, it is not 
clear whether this latter effect is specific to post-burn HSc fibro-
blasts or a general phenomenon in fibrosis. 
Our own results on the cells studied here (data not shown) and 
those of others [20] have shown that there is a steady decrease in 
capacity to synthesize collagen with increasing passage number. 
This phenomenon seems to be selective because other cell proteins 
such as Nb29 (present results) or TIMP I (unpublished results), 
whose mRNAs do not change, may have little effect. In conclusion, 
we have demonstrated that fibroblasts cultured from post-burn HSc 
and normal skin express RNA for TGF-Pt and that there is a selec-
tive decline in the abundance of this message with increasing pas-
sage number. This finding suggests that the more dramatic eleva-
tion of mRNA for type I and type III collagen in HSc tissue [5] 
compared to cultured cells [4] may be due to locally synthesized 
TGF-Pt and/or other factors in healing wound. 
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